The combination of Optym, Emmes' ophthalmology certification unit, and Clinical Edge will make the organization a leader in ophthalmic certification and training services
Funds raised will be used to develop technology and foster healthcare partnerships
One in two women with advanced ovarian cancer has an HRD-positive tumor
The company has partnered with Neethi, a Kerala state cooperative consumers federation limited company, to run this program in Kerala
Younger Indians have a 10 times higher rate of heart attack
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
The Accelerator will develop products and solutions that will support Sanofi’s mission to transform the practice of medicine with the use of digital, data and artificial intelligence (AI).
Deucravacitinib is currently under regulatory review in multiple regions, including the U.S., Europe and Japan, and would be the first selective allosteric tyrosine kinase 2 (TYK2) inhibitor approved for the treatment of any disease
Subscribe To Our Newsletter & Stay Updated
